1 - 10 of 7665 Results
Title
Year
-
RESTRICTEDTitle: Concerns with the new biological research criteria for synucleinopathy – Authors' replyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 23Issue #: 7Start Page: 663End Page: 666Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(24)00233-3Citation Count: 0
-
RESTRICTEDTitle: Synchronous Measurements of Extracellular Action Potentials and Neurochemical Activity with Carbon Fiber Electrodes in Nonhuman PrimatesJournal Name: eneuroPublisher: Society for NeuroscienceVol:Issue #:Start Page: ENEURO.0001End Page: 24.2024Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1523/eneuro.0001-24.2024Citation Count: 0
-
RESTRICTEDTitle: Randomized controlled trial of intermittent hypoxia in Parkinson’s disease: study rationale and protocolJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 24Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1186/s12883-024-03702-3Citation Count: 0
-
RESTRICTEDTitle: Very low levels of ABCA7 in the cerebrum and Alzheimer’s disease onset between the ages of 60 and 80 independently of APOEJournal Name: Journal of Neuropathology & Experimental NeurologyPublisher: Oxford University Press (OUP)Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1093/jnen/nlae060Citation Count: 0
-
RESTRICTEDTitle: The hexosamine biosynthetic pathway rescues lysosomal dysfunction in Parkinson’s disease patient iPSC derived midbrain neuronsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41467-024-49256-3Citation Count: 0
-
RESTRICTEDTitle: Plasma extracellular vesicle tau and TDP-43 as diagnostic biomarkers in FTD and ALSJournal Name: Nature MedicinePublisher: Springer Science and Business Media LLCVol: 30Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41591-024-02937-4Best OA location URL: https://www.nature.com/articles/s41591-024-02937-4.pdfCitation Count: 1
-
RESTRICTEDTitle: Plasma proteomics identify biomarkers predicting Parkinson’s disease up to 7 years before symptom onsetJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41467-024-48961-3Best OA location URL: https://www.nature.com/articles/s41467-024-48961-3.pdfCitation Count: 0
-
RESTRICTEDTitle: Neurovascular and immune factors of vulnerability of substantia nigra dopaminergic neurons in non-human primatesJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41531-024-00735-wCitation Count: 0
-
RESTRICTEDTitle: Disease progression modelling reveals heterogeneity in trajectories of Lewy-type α-synuclein pathologyJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41467-024-49402-xBest OA location URL: https://doi.org/10.1038/s41467-024-49402-xCitation Count: 0
-
RESTRICTEDTitle: Ligand-based design of [18F]OXD-2314 for PET imaging in non-Alzheimer’s disease tauopathiesJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41467-024-49258-1Citation Count: 0